Protara Tx (TARA): Nilai pasar

Logo grafis Protara (TARA)

The market trend on the GURU.Markets platform for Protara Therapeutics (TARA), which has a market capitalization of 0.15, is driven by the implementation of eco-friendly filtration systems in laboratories and the automation of molecular screening via robotics. The business relies on the development of anti-tumor agents while minimizing harmful emissions. Stability is ensured by management's pragmatic approach to expenses and the transparent development of the TARA-002 project to extend the utility of existing resources.

protaratx.com - Kapitalisasi pasar TARA (periode 04.07.2022 - 22.10.2026)

Rincian metrik lan analitis perusahaan Protara Tx (TARA)

Pambiji fundamental perusahaan:Protara Therapeutics, Inc. TARA
Sampel barang Protara Therapeutics

Protara Therapeutics (TARA) focuses on creating monopoly solutions for the therapy of rare oncological diseases, including the drug TARA-002. An analysis of the company's aggregate market capitalization reflects the current value of all outstanding shares. This indicator measures the overall market valuation of the business, signaling investor confidence in the development potential. Sharp fluctuations on the chart indicate high volatility in expectations, making the asset sensitive to any news regarding drug registration.

Pesaing Protara Therapeutics (TARA)

Kapitalisasi pasar ONC (BeiGene)|Kapitalisasi pasar Halozyme Therapeutics, Inc. HALO|RVMD - Nilai pasar|Nilai pasar AAPG (Ascentage Pharma Corp)|CGON: Kapitalisasi pasar|urogen.com (URGN) - Kapitalisasi pasar|BCAX (Bicara Therapeutics) - Kapitalisasi pasar|Biji pasar Personalis Inc (PSNL)|Kapitalisasi pasar ERAS|Kapitalisasi pasar Delcath Corp (DCTH)|Nilai pasar Y-mAbs Therapeutics YMAB|AURA: Kapitalisasi pasar|Candel - Kapitalisasi pasar|Accuray Inc (ARAY) - Biji pasar|SLS: Kapitalisasi pasar|Nilai pasar Actuate Therapeutics Inc (ACTU)|Nilai pasar Citius Oncology, Inc.|HURA: Nilai pasar|Biji pasar FATE (Fate Therapeutics)|WHWK (aadibio.com) - Nilai pasar|Kapitalisasi pasar TCRX (TScan Therapeutics, Inc.)|CSBR - Biji pasar|XBIT: Biji pasar|CVM - Kapitalisasi pasar|OS Therapies (OSTX) - Nilai pasar|Radiopharm Theranostics Ltd - Nilai pasar|ARTV (Artiva Biotherapeutics Inc.) - Kapitalisasi pasar|Nilai pasar Adlai Nortye Limited ANL|Nilai pasar Veru Inc. (VERU)|TPST: Biji pasar|Nilai pasar Xilio Therapeutics XLO|Nilai pasar RENB|MURA - Nilai pasar|Nilai pasar Kairos Pharma Ltd|OKUR (onkuretherapeutics.com) - Biji pasar|GDTC: Nilai pasar|CRIS (Curis Inc.) - Kapitalisasi pasar|Kapitalisasi pasar Apollomics Corp|Nilai pasar Tharimmune Corp (THAR)|ADVB (advanbiomed.com) - Nilai pasar|Kapitalisasi pasar GNPX (Genprex, Inc.)|Kapitalisasi pasar Calidi Biotherapeutics Inc. CLDI|SBFM: Biji pasar|Nilai pasar XBIO (Xenetic Biosciences)|SLRX (Salarius) - Biji pasar|PPBT: Nilai pasar|AONC (American Oncology Network Inc) - Kapitalisasi pasar|BGNE: Nilai pasar|Kapitalisasi pasar CKPT|ELEV - Nilai pasar|Nilai pasar iCAD ICAD|Nilai pasar IKNA|Notable Labs, Ltd. - Kapitalisasi pasar|VIRX - Kapitalisasi pasar|MorphoSys (MOR) - Nilai pasar|Biji pasar NAYA (NAYA Biosciences Inc)|AAPGV (Ascentage Pharma Group Ltd) - Kapitalisasi pasar